Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.31 |
| ▸ | CMA1 | P23946 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23839331 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHR | |
| SCHEMBL12189706 | 0.78 | — | — | |
| SCHEMBL13176819 | 0.75 | — | — | |
| SCHEMBL7967806 | 0.72 | — | — | |
| SCHEMBL12600958 | 0.69 | HDAC6 (0.37) | TSHR | |
| SCHEMBL2824852 | 0.69 | ALDH1A1 (0.53) | ALDH1A1TSHRPRSS1CTSGCTRB1 | |
| SCHEMBL27804583 | 0.67 | KDM4E (0.62) | ALDH1A1TSHR | |
| SCHEMBL15345266 | 0.67 | KDM4E (0.62) | ALDH1A1TSHR | |
| SCHEMBL11219823 | 0.67 | ALDH1A1 (0.43) | ALDH1A1TSHRPRSS1CTSGCTRB1 | |
| SCHEMBL775733 | 0.67 | ALDH1A1 (0.50) | ALDH1A1TSHRPRSS1CTSGCTRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210388002-A1 | DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2021-12-16 | — | — | US | disclosed |
| US-20210387990-A1 | METHOD FOR PRODUCING DIMETHOXYBENZENE COMPOUND | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2021-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210387990-A1 | METHOD FOR PRODUCING DIMETHOXYBENZENE COMPOUND | CYP1B1, PAH, CYP4B1 | ALDH1A1 40/4885TSHR 4443/4885PRSS1 3387/4885 |
| US-20210388002-A1 | DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS | DDC, PAH, DDT | ALDH1A1 12/4885TSHR 4454/4885PRSS1 2796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.